World's Best Scientists 2026 revealed!
Carlos S. Moreno

Carlos S. Moreno

D-Index & Metrics

Molecular Biology

D-Index
56
Citations
10889
World Ranking
2208
National Ranking
1094

Carlos S. Moreno publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Carlos S. Moreno sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 150 publications — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Carlos S. Moreno D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Carlos S. Moreno sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 56 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Carlos S. Moreno is affiliated with Emory University in the United States and focuses their research primarily in the fields of Biochemistry, Genetics and Molecular Biology, and Medicine. Their scholarly output spans several subfields including Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology, and Genetics.

The scientist's work covers a variety of topics, with notable emphasis on MicroRNA in disease regulation, Prostate Cancer Treatment and Research, Cancer-related molecular mechanisms research, Cancer Genomics and Diagnostics, RNA modifications and cancer, Prostate Cancer Diagnosis and Treatment, and Parkinson's Disease Mechanisms and Treatments.

Frequent coauthors contributing to their publications include Martin G. Sanda, Adeboye O. Osunkoya, Lukas Pavelka, Enrico Glaab, and Rejko Krüger.

Moreno's research has appeared in several publication venues with multiple contributions to Cancer Research, Scientific Reports, BMC Genomics, bioRxiv (Cold Spring Harbor Laboratory), and Cell.

Among the recent papers authored or co-authored by Carlos S. Moreno are:

  • Parkinson's disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions, 2020, BMC Biology
  • An expanded universe of cancer targets, 2021, Cell
  • High throughput, label-free isolation of circulating tumor cell clusters in meshed microwells, 2022, Nature Communications
  • Systematic discovery of mutation-directed neo-protein-protein interactions in cancer, 2022, Cell
  • Combined HER3-EGFR score in triple-negative breast cancer provides prognostic and predictive significance superior to individual biomarkers, 2020, Scientific Reports

Best Publications

  • Correction: Corrigendum: The OncoPPi network of cancer-focused protein–protein interactions to inform biological insights and therapeutic strategies

    Zenggang Li;Andrei A. Ivanov;Rina Su;Valentina Gonzalez-Pecchi

  • MTA3, a Mi-2/NuRD Complex Subunit, Regulates an Invasive Growth Pathway in Breast Cancer

    Naoyuki Fujita;David L. Jaye;Masahiro Kajita;Cissy Geigerman

  • MR imaging predictors of molecular profile and survival: Multi-institutional study of the TCGA glioblastoma data set

    David A. Gutman;Lee A.D. Cooper;Scott N. Hwang;Chad A. Holder

  • Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers.

    Andrew N. Young;Andrew N. Young;Mahul B. Amin;Carlos S. Moreno;So Dug Lim

  • Relative Burden of Large CNVs on a Range of Neurodevelopmental Phenotypes

    Santhosh Girirajan;Zoran Brkanac;Bradley P. Coe;Carl Baker

  • Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells.

    Pengbo Liu;Sumathi Ramachandran;Mohamed Ali Seyed;Christopher D. Scharer

  • Wnt signaling in triple negative breast cancer is associated with metastasis

    Nandini Dey;Benjamin G Barwick;Carlos S Moreno;Maja Ordanic-Kodani

  • WD40 Repeat Proteins Striatin and S/G2 Nuclear Autoantigen Are Members of a Novel Family of Calmodulin-binding Proteins That Associate with Protein Phosphatase 2A

    Carlos S. Moreno;Susan Park;Kasey Nelson;Danita Ashby

  • Genome-Wide Promoter Analysis of the SOX4 Transcriptional Network in Prostate Cancer Cells

    Christopher D. Scharer;Colleen D. McCabe;Mohamed Ali-Seyed;Michael F. Berger

  • The Tumor Microenvironment Strongly Impacts Master Transcriptional Regulators and Gene Expression Class of Glioblastoma

    Lee Cooper;David Andrew Gutman;Candace Chisolm;Christina Appin

  • Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses.

    Carlos S. Moreno;Chheng-Orn Evans;Xianquan Zhan;Mammerhi Okor

  • Expression of HLA-A,B,C Antigens on Primary and Metastatic Tumor Cell Populations of Human Carcinomas

    Carlos Cordon-Cardo;Zvi Fuks;Marija Drobnjak;Carlos Moreno

  • The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies

    Zenggang Li;Andrei A. Ivanov;Rina Su;Rina Su;Rina Su;Valentina Gonzalez-Pecchi

  • CREB regulates MHC class II expression in a CIITA-dependent manner.

    Carlos S Moreno;Guy W Beresford;Pascale Louis-Plence;Ann C Morris

  • Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity

    Marcel W. Coolen;Clare Stirzaker;Jenny Z. Song;Aaron L. Statham

  • Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class

    W. Caleb Rutledge;Jun Kong;Jingjing Gao;David A. Gutman

  • Methylation of the Protein Phosphatase 2A Catalytic Subunit Is Essential for Association of Bα Regulatory Subunit But Not SG2NA, Striatin, or Polyomavirus Middle Tumor Antigen

    Xing Xian Yu;Xianxing Du;Carlos S. Moreno;Richard E. Green

  • Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells.

    Birdal Bilir;Omer Kucuk;Omer Kucuk;Carlos S Moreno;Carlos S Moreno

  • Molecular analysis of G1B and G3A IFNγ mutants reveals that defects in CIITA or RFX result in defective class II MHC and li gene induction

    Keh Chuang Chin;Catherine Mao;Cheryl Skinner;James L. Riley

  • Molecular classification of renal tumors by gene expression profiling.

    Audrey N. Schuetz;Qiqin Yin-Goen;Qiqin Yin-Goen;Mahul B. Amin;Carlos S. Moreno

Frequent Co-Authors

Lee Cooper
Lee Cooper Northwestern University
Daniel J. Brat
Daniel J. Brat Northwestern University
Joel H. Saltz
Joel H. Saltz Stony Brook University
Arun Seth
Arun Seth Sunnybrook Health Science Centre
Fusheng Wang
Fusheng Wang Stony Brook University
Tahsin Kurc
Tahsin Kurc Stony Brook University
Haian Fu
Haian Fu Emory University
Fadlo R. Khuri
Fadlo R. Khuri American University of Beirut
Paula M. Vertino
Paula M. Vertino Emory University
David C. Pallas
David C. Pallas Emory University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Are you considering alternative or complementary study paths to Molecular Biology? There are several online degree programs and career routes that can enhance your skill set or open new opportunities in science and related fields.

For students interested in integrating diverse subjects, affordable online interdisciplinary studies degrees offer a flexible and cost-effective way to combine molecular biology with other disciplines such as environmental science, health, or data analytics.

Careers outside the lab, like history or library science, can complement your molecular biology background. For example, scientific historians play vital roles in research and academia—if you're interested, you may want to know how much do historians make before pursuing a graduate degree.

Alternatively, becoming a science librarian is another impactful career. If you’re curious about the costs, check out how much does it cost to become a librarian to make an informed decision.

Finally, for those with an interest in healthcare and communication, accredited online speech-language pathology programs are available. Review asha accredited slpa programs for professional certification options.

Best Scientists Citing Carlos S. Moreno

Trending Scientists